ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,667Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 973

$456K Total Retail Price of All Prescriptions

Rank: 177 out of 973

564 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,346 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 552 495 1 1
LISINOPRIL 495 397 2 3
LEVOTHYROXINE SODIUM 423 358 3 2
OMEPRAZOLE 417 338 4 5
HYDROCODONE-ACETAMINOPHEN 393 217 S3 5 4
METFORMIN HCL 292 269 6 8
HYDROCHLOROTHIAZIDE 268 232 7 11
WARFARIN SODIUM 256 215 8 10
AMLODIPINE BESYLATE 251 219 9 7
FUROSEMIDE 226 203 10 6
LOSARTAN POTASSIUM 218 192 11 19
ATENOLOL 211 192 12 16
CITALOPRAM HBR 208 176 13 14
ATORVASTATIN CALCIUM 179 144 14 15
METOPROLOL TARTRATE 174 161 15 13
GABAPENTIN 167 98 16 12
PRAVASTATIN SODIUM 156 151 17 22
POTASSIUM CHLORIDE 135 124 18 9
METOPROLOL SUCCINATE 132 115 19 17
SERTRALINE HCL 114 87 20 21
PROAIR HFA 106 52 21 54
CARVEDILOL 103 72 22 27
TRAMADOL HCL 97 54 23 18
MELOXICAM 94 80 24 23
ZOLPIDEM TARTRATE 90 67 25 20
TAMSULOSIN HCL 90 90 25 28
ALLOPURINOL 89 83 27 29
ADVAIR DISKUS 88 57 28 60
RANITIDINE HCL 84 58 29 45
AMITRIPTYLINE HCL 82 55 R 30 52
GLYBURIDE 76 62 R 31 59
FLUOXETINE HCL 72 17 32 56
FENOFIBRATE 71 66 33 77
LOVASTATIN 68 68 34 38
FAMOTIDINE 68 58 34 61
CYMBALTA 68 46 34 40
ENALAPRIL MALEATE 66 59 37 55
FINASTERIDE 65 65 38 90
ALENDRONATE SODIUM 64 64 39 24
FLUTICASONE PROPIONATE 63 51 40 35
METHADONE HCL 63 28 S2 40 129
ZETIA 62 57 42 81
CLOPIDOGREL 61 50 43 44
CRESTOR 60 50 44 34
LANTUS 59 33 45 39
PREDNISONE 56 34 46 33
GEMFIBROZIL 54 50 47 83
LYRICA 52 18 48 118
LEVOFLOXACIN 51 40 49 84
PANTOPRAZOLE SODIUM 51 41 49 37
IBUPROFEN 50 27 51 102
GLIMEPIRIDE 50 45 51 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.